Drugplain

Dutasteride and Tamsulosin Hydrochloride .5 mg/1

Dutasteride and Tamsulosin Hydrochloride · CAPSULE · Aurobindo Pharma Limited

No Recall History
Plain English

This prescription medication combines two active ingredients to treat benign prostatic hyperplasia (enlarged prostate) in men. Dutasteride works by reducing prostate size, while tamsulosin helps relax muscles in the prostate and bladder to improve urinary flow.

Key Facts

Brand Name
Dutasteride and Tamsulosin Hydrochloride
Generic Name
Dutasteride and Tamsulosin Hydrochloride
NDC Code (Product)
59651-063
Manufacturer
Aurobindo Pharma Limited
Strength
.5 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
ANDA213300
Drug Class
5-alpha Reductase Inhibitor [EPC]
Marketing Start
07/18/2024

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

atrial fibrillation9 reports
hypomagnesaemia8 reports
dizziness7 reports
hypotension7 reports
cerebral hypoperfusion6 reports
chest pain6 reports
gait disturbance6 reports
palpitations6 reports
constipation5 reports
feeling cold5 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE Dutasteride and tamsulosin hydrochloride capsules are a combination of dutasteride, a 5-alpha-reductase inhibitor, and tamsulosin, an alpha-adrenergic antagonist, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. ( 1.1 ) Limitations of Use: Dutasteride-containing products, including dutasteride and tamsulosin hydrochloride capsules, are not approved for the prevention of prostate cancer. ( 1.2 ) 1.1 Benign Prostatic Hyperplasia (BPH) Treatment Dutasteride and tamsulosin hydrochloride capsules are indicated for the treatment of symptomatic BPH in men with an enlarged prostate. 1.2 Limitations of Use Dutasteride-containing products, including dutasteride and tamsulosin hydrochloride capsules, are not approved for the prevention of prostate cancer.

Dosage & Administration

2 DOSAGE AND ADMINISTRATION The recommended dosage of dutasteride and tamsulosin hydrochloride capsules is 1 capsule (0.5 mg dutasteride and 0.4 mg tamsulosin hydrochloride) taken once daily approximately 30 minutes after the same meal each day. The capsules should be swallowed whole and not chewed or opened. Contact with the contents of the dutasteride and tamsulosin hydrochloride capsule may result in irritation of the oropharyngeal mucosa. Take one capsule daily approximately 30 minutes after the same meal each day. ( 2 ) Swallow capsule whole. ( 2 )

Contraindications

4 CONTRAINDICATIONS Dutasteride and tamsulosin hydrochloride capsules are contraindicated for use in: Pregnancy. Dutasteride use is contraindicated in females who are pregnant. In animal reproduction and developmental toxicity studies, dutasteride inhibited development of male fetus external genitalia. Therefore, dutasteride and tamsulosin hydrochloride capsules may cause fetal harm when administered to a pregnant female. [see Warnings and Precautions ( 5.6 ), Use in Specific Populations ( 8.1 ) ] . Patients with previously demonstrated, clinically significant hypersensitivity (e.g., serious skin reactions, angioedema, urticaria, pruritus, respiratory symptoms) to dutasteride, other 5-alpha-reductase inhibitors, tamsulosin, or any other component of dutasteride and tamsulosin hydrochloride capsules [see Adverse Reactions ( 6.2 ) ] . Pregnancy. Dutasteride use is contraindicated in females who are pregnant. ( 4 , 5.6 , 8.1 ) Patients with previously demonstrated, clinically significant hypersensitivity (e.g., serious skin reactions, angioedema, urticaria, pruritus, respiratory symptoms) to dutasteride, other 5-alpha-reductase inhibitors, tamsulosin, or any component of dutasteride a

Drug Interactions

7 DRUG INTERACTIONS There have been no drug interaction trials using dutasteride and tamsulosin hydrochloride capsules. The following sections reflect information available for the individual components. 7.1 Cytochrome P450 Inhibition Dutasteride Dutasteride is extensively metabolized in humans by the CYP3A4 and CYP3A5 isoenzymes. The effect of potent CYP3A4 inhibitors on dutasteride has not been studied. Because of the potential for drug-drug interactions, use caution when prescribing a dutasteride-containing product, including dutasteride and tamsulosin hydrochloride capsules, to patients taking potent, chronic CYP3A4 enzyme inhibitors (e.g., ritonavir) [see Clinical Pharmacology ( 12.3 ) ] . Tamsulosin Strong and Moderate Inhibitors of CYP3A4 or CYP2D6: Tamsulosin is extensively metabolized, mainly by CYP3A4 or CYP2D6. Concomitant treatment with ketoconazole (a strong inhibitor of CYP3A4) resulted in increases in the C max and AUC of tamsulosin by factors of 2.2 and 2.8, respectively. Concomitant treatment with paroxetine (a strong inhibitor of CYP2D6) resulted in increases in the C max and area under the concentration-time curve (AUC) of tamsulosin by factors of 1.3 and 1.6, re

Adverse Reactions

6 ADVERSE REACTIONS The most common adverse reactions, reported in ≥1% of subjects treated with coadministered dutasteride and tamsulosin are ejaculation disorders, impotence, decreased libido, dizziness, and breast disorders. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact AvKARE at 1-855-361-3993 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience The clinical efficacy and safety of coadministered dutasteride and tamsulosin, which are individual components of dutasteride and tamsulosin hydrochloride capsules, have been evaluated in a multicenter, randomized, double-blind, parallel group trial (the Combination with Alpha-Blocker Therapy, or CombAT, trial). Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trial of another drug and may not reflect the rates observed in practice. The most common adverse reactions reported in subjects receiving coadministered dutasteride and tamsulosin were impotence, decreased libido, breast disorders (including breast enlargement and tenderness), ejaculation disorders, and d

Frequently Asked Questions

What is Dutasteride and Tamsulosin Hydrochloride used for?

This prescription medication combines two active ingredients to treat benign prostatic hyperplasia (enlarged prostate) in men. Dutasteride works by reducing prostate size, while tamsulosin helps relax muscles in the prostate and bladder to improve urinary flow.

Is Dutasteride and Tamsulosin Hydrochloride a controlled substance?

Dutasteride and Tamsulosin Hydrochloride is not classified as a controlled substance by the DEA.

What is the generic name for Dutasteride and Tamsulosin Hydrochloride?

The generic name for Dutasteride and Tamsulosin Hydrochloride is Dutasteride and Tamsulosin Hydrochloride. There are 3 other brand versions of Dutasteride and Tamsulosin Hydrochloride.

What is the NDC code for Dutasteride and Tamsulosin Hydrochloride .5 mg/1?

The NDC (National Drug Code) for Dutasteride and Tamsulosin Hydrochloride .5 mg/1 is 59651-063, listed by Aurobindo Pharma Limited.

Product NDC

59651-063

Package NDC

59651-063-30

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)